- Home
- VYNE vs EVGN Comparison
VYNE vs EVGN Comparison
Compare VYNE & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- EVGN
- Stock Information
- Founded
- VYNE 2003
- EVGN 1999
- Country
- VYNE United States
- EVGN Israel
- Employees
- VYNE N/A
- EVGN N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- VYNE Health Care
- EVGN Industrials
- Exchange
- VYNE Nasdaq
- EVGN Nasdaq
- Market Cap
- VYNE 12.3M
- EVGN 10.9M
- IPO Year
- VYNE 2018
- EVGN N/A
- Fundamental
- Price
- VYNE $0.38
- EVGN $1.18
- Analyst Decision
- VYNE Buy
- EVGN Strong Buy
- Analyst Count
- VYNE 2
- EVGN 1
- Target Price
- VYNE $8.00
- EVGN $3.50
- AVG Volume (30 Days)
- VYNE 1.7M
- EVGN 50.9K
- Earning Date
- VYNE 11-06-2025
- EVGN 11-20-2025
- Dividend Yield
- VYNE N/A
- EVGN N/A
- EPS Growth
- VYNE N/A
- EVGN N/A
- EPS
- VYNE N/A
- EVGN N/A
- Revenue
- VYNE $524,000.00
- EVGN $9,444,000.00
- Revenue This Year
- VYNE N/A
- EVGN N/A
- Revenue Next Year
- VYNE N/A
- EVGN $12.35
- P/E Ratio
- VYNE N/A
- EVGN N/A
- Revenue Growth
- VYNE 6.29
- EVGN 42.25
- 52 Week Low
- VYNE $0.28
- EVGN $0.95
- 52 Week High
- VYNE $4.30
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- VYNE 55.03
- EVGN 44.25
- Support Level
- VYNE $0.35
- EVGN $1.15
- Resistance Level
- VYNE $0.40
- EVGN $1.25
- Average True Range (ATR)
- VYNE 0.03
- EVGN 0.06
- MACD
- VYNE 0.00
- EVGN -0.00
- Stochastic Oscillator
- VYNE 74.75
- EVGN 33.35
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.